• Explore /
  • Poster
  • / Alliance A031501: Phase III randomized adjuvant study of MK-3475 (pembrolizumab) in muscle-invasive and locally advanced urothelial carcinoma (MIBC) (AMBASSADOR) versus observation.

Alliance A031501: Phase III randomized adjuvant study of MK-3475 (pembrolizumab) in muscle-invasive and locally advanced urothelial carcinoma (MIBC) (AMBASSADOR) versus observation.

Abstract Poster

Authors

Andrea Apolo

Andrea B. Apolo

Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

Andrea B. Apolo , Jonathan E. Rosenberg , William Y. Kim , Ronald C. Chen , Guru Sonpavde , Sandy Srinivas , Amir Mortazavi , Colleen Watt , Marissa Mallek , Katherine Graap , Carlos Diaz , Meagan Odegaard , Karla V. Ballman , Michael J. Morris

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

NCT03244384

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr TPS504)

DOI

10.1200/JCO.2019.37.7_suppl.TPS504

Abstract #

TPS504

Poster Bd #

N14

Abstract Disclosures

Similar Posters

First Author: Greg Andrew Durm

First Author: Yohann Loriot

First Author: David I. Quinn

First Author: Gerard Zalcman